Modeling and analysis of a virus that replicates selectively in tumor cells
From MaRDI portal
Publication:886888
DOI10.1006/bulm.2001.0245zbMath1323.92112OpenAlexW2041468629WikidataQ45736176 ScholiaQ45736176MaRDI QIDQ886888
Lawrence M. Wein, Joseph T. Wu, David H. Kirn, Helen M. Byrne
Publication date: 27 October 2015
Published in: Bulletin of Mathematical Biology (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1006/bulm.2001.0245
Related Items (40)
Bistability in a model of tumor-immune system interactions with an oncolytic viral therapy ⋮ Slow-fast model and therapy optimization for oncolytic treatment of tumors ⋮ A critical virus production rate for efficiency of oncolytic virotherapy ⋮ Optimization of virotherapy for cancer ⋮ Dynamical properties and tumor clearance conditions for a nine-dimensional model of bladder cancer immunotherapy ⋮ The role of TNF-\(\alpha\) inhibitor in glioma virotherapy: a mathematical model ⋮ Mathematical and computational modeling for tumor virotherapy with mediated immunity ⋮ On a mathematical model of tumor-immune system interactions with an oncolytic virus therapy ⋮ Hopf bifurcation without parameters in deterministic and stochastic modeling of cancer virotherapy. I ⋮ Modeling oncolytic virotherapy: is complete tumor-tropism too much of a good thing? ⋮ Mathematical modelling of the use of macrophages as vehicles for drug delivery to hypoxic tumour sites ⋮ Oncolytic virus treatment of human breast cancer cells: modelling therapy efficacy ⋮ Agent-based and continuum models for spatial dynamics of infection by oncolytic viruses ⋮ A FREE BOUNDARY PROBLEM MODELLING CANCER RADIOVIROTHERAPY ⋮ Oscillation thresholds via the novel MBR method with application to oncolytic virotherapy ⋮ Analysis of a mathematical model for tumor therapy with a fusogenic oncolytic virus ⋮ The role of tumor activation and inhibition with saturation effects in a mathematical model of tumor and immune system interactions undergoing oncolytic viral therapy ⋮ Bifurcations and Chaotic Dynamics in a Tumour-Immune-Virus System ⋮ Mathematical modelling of a hypoxia-regulated oncolytic virus delivered by tumour-associated macrophages ⋮ The role of the innate immune system in oncolytic virotherapy ⋮ Backward Hopf bifurcation in a mathematical model for oncolytic virotherapy with the infection delay and innate immune effects ⋮ A mathematical model for cell cycle-specific cancer virotherapy ⋮ The role of viral infectivity in oncolytic virotherapy outcomes: a mathematical study ⋮ Modelling the response of spatially structured tumours to chemotherapy: drug kinetics ⋮ Growth of adult spinal cord in knifefish: development and parametrization of a distributed model ⋮ Numerical study for a model of tumor virotherapy ⋮ Spatial model for oncolytic virotherapy with lytic cycle delay ⋮ The competitive dynamics between tumor cells, a replication-competent virus and an immune response ⋮ Mathematical modeling of cancer radiovirotherapy ⋮ Modeling of cancer virotherapy with recombinant measles viruses ⋮ A mathematical model for oncolytic virus spread using the telegraph equation ⋮ A Nonlinear Mathematical Model of Virus-Tumor-Immune System Interaction: Deterministic and Stochastic Analysis ⋮ A mathematical model that combines chemotherapy and oncolytic virotherapy as an alternative treatment against a glioma ⋮ Computation of the conditions for anti-angiogenesis and gene therapy synergistic effects: sensitivity analysis and robustness of target solutions ⋮ A free boundary problem modeling the cell cycle and cell movement in multicellular tumor spheroids ⋮ A mathematical model of combined therapies against cancer using viruses and inhibitors ⋮ Analysis of a multiple delays model for treatment of cancer with oncolytic virotherapy ⋮ A mathematical model of oncolytic virotherapy with time delay ⋮ A PARABOLIC–HYPERBOLIC FREE BOUNDARY PROBLEM MODELLING TUMOR TREATMENT WITH VIRUS ⋮ Bifurcation analysis of the cancer virotherapy system with time delay and diffusion
This page was built for publication: Modeling and analysis of a virus that replicates selectively in tumor cells
